Clinical Trial Update: Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib [Phase 1]

View source ↗

Summary

A Phase 1 study in healthy volunteers to assess whether omeprazole and ranitidine alter the pharmacokinetics of vandetanib, a therapy used for medullary thyroid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medullary Thyroid Carcinoma

Drugs mentioned

• PRILOSEC (Omeprazole magnesium)
• Vandetanib (vandetanib)
• Zantac (ranitidine)

Snippet

Sponsor: Sanofi | Conditions: Medullary Thyroid Cancer | Phase 1 | Status: COMPLETED